reports
Y-mAbs to Announce First Quarter 2024 Financial and Operating Results ...
Y-mAbs to Announce First Quarter 2024 Financial and Operating Results on May 7, 2024 The Company will host a conference call and webcast on Wednesday, May 8, 2024 at 8:00 a.m. ET NEW YORK, April 26, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today announced that it will report its financial results for the quarter ended March 31, 2024, on Tuesday, May 7, 2024, after the close of the U.S. financial markets. The announcement will be followed by a conference call and webcast with the investment community on Wednesday, May 8, 2024, at 8:00 ...
Decisions of the Annual General Meeting of Shareholders of Grigeo AB
Decisions of the Annual General Meeting of Shareholders of Grigeo AB The Annual General Meeting of shareholders of Grigeo AB (hereinafter – the Company), was held on 26th of April 2024. The Annual General Meeting of shareholders of the Company was attended by the Chief Executive Officer of the Company, the members of the Board and the employees of the Company, who were able to provide information relating to the agenda of the Annual General Meeting of shareholders. The Annual General Meeting of shareholders adopted the following decisions: To assent to the Company's Remuneratio...
AB „Grigeo“ eilinio visuotinio akcininkų susirinkimo sprendimai
AB „Grigeo“ eilinio visuotinio akcininkų susirinkimo sprendimai 2024 m. balandžio 26 d. įvyko AB „Grigeo“ (toliau – Bendrovė) eilinis visuotinis akcininkų susirinkimas. Bendrovės eiliniame akcininkų susirinkime dalyvavo Bendrovės generalinis direktorius, valdybos nariai bei Bendrovės darbuotojai, galintys pateikti informaciją, susijusią su visuotinio akcininkų susirinkimo darbotvarke. Bendrovės eilinis visuotinis akcininkų susirinkimas priėmė šiuos sprendimus: Pritarti Bendrovės atlygio ataskaitai, kuri pateikiama kaip Bendrovės 2023 m. konsoliduotojo metinio pranešimo dalis.Pa...
JD.com to Report First Quarter 2024 Financial Results on May 16, 2024
JD.com to Report First Quarter 2024 Financial Results on May 16, 2024 BEIJING, April 26, 2024 (GLOBE NEWSWIRE) -- JD.com, Inc. (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a leading supply chain-based technology and service provider, today announced that it plans to release its unaudited first quarter 2024 financial results on Thursday, May 16, 2024, before the U.S. market opens. JD.com’s management will hold a conference call at 8:00 am, Eastern Time on May 16, 2024, (8:00 pm, Beijing/Hong Kong Time on May 16, 2024) to discuss the first quarter 2024 financial resul...
Vivid Seats to Report First Quarter 2024 Financial Results
Vivid Seats to Report First Quarter 2024 Financial Results CHICAGO, April 26, 2024 (GLOBE NEWSWIRE) -- Vivid Seats Inc. (NASDAQ:SEAT) (“Vivid Seats”), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, will report financial results for the first quarter 2024 on Tuesday, May 7, 2024, before the U.S. stock market opens. Management will discuss the results on a webcast at 8:30 a.m. ET. The live webcast and replay can be accessed at . About Vivid Seats Founded in 200...
Village Farms International to Report Q1/24 Results on May 8, 2024
Village Farms International to Report Q1/24 Results on May 8, 2024 Management to Host Conference Call May 8 at 8:30 a.m. ET VANCOUVER, British Columbia and ORLANDO, Fla., April 26, 2024 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today announced it will host a conference call to discuss its first quarter 2024 financial results on Wednesday, May 8, 2024, at 8:30 a.m. ET. Participants can access the conference call by telephone at (800) 715-9871 or (646) 307-1963, or via the Internet at (conference ID 7790112). The live ques...
NGS Group AB: Offentliggör årsredovisning 2023
NGS Group AB: Offentliggör årsredovisning 2023 Härmed offentliggör NGS Group AB (publ) sin årsredovisning för 2023. Årsredovisningen finns även tillgänglig på bolagets hemsida För ytterligare information kontakta: Thomas Plate, CFO för NGS Group på telefon 076-894 9239 eller mailadress . Denna information är sådan som NGS Group AB (publ) är skyldig att offentliggöra enligt lagen om värdepappersmarknaden, lagen om handel med finansiella instrument samt Nasdaq Stockholms regelverk. Informationen lämnades för offentliggörande den 26 april 2024. Bilagor ...
Digitalist Group Plc - Managers' Transactions
Digitalist Group Plc - Managers' Transactions Digitalist Group Plc Managers’ transactions 26 April 2024 at 14:00 Digitalist Group Plc - Managers' Transactions ____________________________________________Person subject to the notification requirement Name: Turret Oy Ab Position: Closely associated person (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Paul Ehrnrooth Position: Member of the Board (2):Person Discharging Managerial Responsibilities In Issuer Name: Peter Eriksson Position: Member of the Board Issuer: Digitalist Group Oyj LEI: 74370...
Digitalist Group Oyj - Johdon liiketoimet
Digitalist Group Oyj - Johdon liiketoimet Digitalist Group Oyj Johdon liiketoimet 26.4.2024 klo 14:00 Digitalist Group Oyj - Johdon liiketoimet____________________________________________ Ilmoitusvelvollinen Nimi: Turret Oy Ab Asema: Lähipiiriin kuuluva henkilö (X) Oikeushenkilö (1):Liikkeeseenlaskijassa johtotehtävissä toimiva henkilö Nimi: Paul Ehrnrooth Asema: Hallituksen jäsen/varajäsen (2):Liikkeeseenlaskijassa johtotehtävissä toimiva henkilö Nimi: Peter Eriksson Asema: Hallituksen jäsen/varajäsen Liikkeeseenlaskija: Digitalist Group Oyj LEI: 743700AL68PUX6JMS644 I...
Krystal Biotech to Report First Quarter 2024 Financial Results on May ...
Krystal Biotech to Report First Quarter 2024 Financial Results on May 6, 2024 PITTSBURGH, April 26, 2024 (GLOBE NEWSWIRE) -- (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that it will report its first quarter 2024 financial results on Monday, May 6, 2024, prior to the open of U.S. markets. The Company’s management will also host a conference call and webcast at 8:30 am ET on Monday, May 6, 2024, to discuss the financial results and provide a business update. Investors and the general public can access the live webcast at: . For those unable ...
Bitfarms Schedules First Quarter 2024 Conference Call on May 13, 2024
Bitfarms Schedules First Quarter 2024 Conference Call on May 13, 2024 TORONTO and BROSSARD, Québec, April 26, 2024 (GLOBE NEWSWIRE) -- Bitfarms Ltd. (NASDAQ/TSX: BITF), a global vertically integrated Bitcoin mining company, will report its first quarter 2024 financial results on Monday May13, 2024, before the market opens. Management will host a conference call on the same day at 8:00 am EST. A presentation of the Q1 2024 results will be accessible before the call on the Investor website and can be accessed . Participants may join by calling 877-545-0523 (domestic) or 973-528-0016 (inter...
Macerich Declares the Quarterly Dividend on Its Common Shares
Macerich Declares the Quarterly Dividend on Its Common Shares SANTA MONICA, Calif., April 26, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of the Macerich Company (NYSE: MAC) declared a quarterly cash dividend of $.17 per share of common stock. The dividend is payable on June 3, 2024, to stockholders of record at the close of business on May 20, 2024. About Macerich Macerich is a fully integrated, self-managed, self-administered real estate investment trust (REIT). As a leading owner, operator, and developer of high-quality retail real estate in densely populated and attractive U...
CytoSorbents to Report First Quarter 2024 Operating and Financial Resu...
CytoSorbents to Report First Quarter 2024 Operating and Financial Results PRINCETON, N.J., April 26, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, will report first quarter 2024 operating and financial results after the market close on Thursday, May 9th, 2024. CytoSorbents’ management will host a live conference call and presentation webcast and a question and answer session starting at 4:30PM EDT the same day. Webcast Details:Date: Thursday, May 9th, 202...
Forløb af ordinær generalforsamling i ØK - Selskabsmeddelelse nr. 4/20...
Forløb af ordinær generalforsamling i ØK - Selskabsmeddelelse nr. 4/2024 26. april 2024 Den 26. april 2024 kl. 11.00 afholdtes ordinær generalforsamling i Det Østasiatiske kompagni A/S, i Asia House, Indiakaj 16, 2100 København Ø. På den ordinære generalforsamling blev følgende dagsordenspunkter behandlet: a. Bestyrelsens beretning blev taget til efterretning.b. Årsrapporten for 2023 blev godkendt. c. Der blev meddelt decharge for bestyrelsen og direktionen. d. Anvendelse af årets resultat i overensstemmelse med den godkendte årsrapport blev godkendt.e....
Roper Technologies announces first quarter financial results
Roper Technologies announces first quarter financial results Increasing full year guidance SARASOTA, Fla., April 26, 2024 (GLOBE NEWSWIRE) -- Roper Technologies, Inc. (Nasdaq: ROP) reported financial results for the first quarter ended March 31, 2024. The results in this press release are presented on a continuing operations basis. First quarter 2024 highlights Revenue increased 14% to $1.68 billion; organic revenue increased 8%GAAP DEPS increased 33% to $3.54; adjusted DEPS increased 13% to $4.41GAAP net earnings increased 34% to $382 millionAdjusted EBITDA increased 16% to $676 ...
KE Holdings Inc. to Hold Annual General Meeting on June 14, 2024
KE Holdings Inc. to Hold Annual General Meeting on June 14, 2024 BEIJING, April 26, 2024 (GLOBE NEWSWIRE) -- KE Holdings Inc. (“Beike” or the “Company”) (NYSE: BEKE; HKEX: 2423), a leading integrated online and offline platform for housing transactions and services, today announced that it will hold an annual general meeting of the Company’s shareholders (the “AGM”) at 10:00 a.m. Beijing time on Friday, June 14, 2024 at Oriental Electronic Technology Building, No. 2 Chuangye Road, Haidian District, Beijing, PRC, for the purposes of considering and, if thought fit, passing each of the Prop...
Board Committee Changes
Board Committee Changes Admiral Group Plc (“Admiral”) 26 April 2024 In compliance with Listing Rule 9.6.11(3), Admiral announces the following changes to the roles of the Non-Executive Directors set out below, which became effective immediately following the 2024 Annual General Meeting held on 25 April: Evelyn Bourke Evelyn stepped down as Chair of the Remuneration Committee.Evelyn was appointed as a member of the Audit Committee. Fiona Muldoon Fiona was appointed as Audit Committee Chair. This appointment is subject to the relevant regulatory approvals being received in due course. ...
Atour Lifestyle Holdings Limited Filed 2023 Annual Report on Form 20-F
Atour Lifestyle Holdings Limited Filed 2023 Annual Report on Form 20-F SHANGHAI, China, April 26, 2024 (GLOBE NEWSWIRE) -- Atour Lifestyle Holdings Limited (“Atour” or the “Company”) (NASDAQ: ATAT), a leading hospitality and lifestyle company in China, today announced that the Company has filed its annual report on Form 20-F for the fiscal year ended December 31, 2023 with the U.S. Securities and Exchange Commission (“SEC”) on April 26, 2024. The annual report is available on the Company’s investor relations website at , and on the SEC’s website at . The Company will provide hard copie...
Ocugen to Present on Modifier Gene Therapy Platform at Association for...
Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting MALVERN, Pa., April 26, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the Company will present on its innovative modifier gene therapy platform, including OCU400 for the treatment of retinitis pigmentosa (Phase 3 LiMeliGhT clinical trial), OCU410 for the treatment of geographic atrophy (P...
Archrock Announces Quarterly Cash Dividend and Extends Share Repurchas...
Archrock Announces Quarterly Cash Dividend and Extends Share Repurchase Authorization HOUSTON, April 26, 2024 (GLOBE NEWSWIRE) -- Archrock, Inc. (NYSE: AROC) (“Archrock” or the “Company”) today announced that its Board of Directors has declared a quarterly dividend of $0.165 per share of common stock, or $0.66 per share on an annualized basis. The first quarter 2024 dividend will be paid on May 14, 2024 to all stockholders of record on May 7, 2024. The first quarter 2024 dividend per share amount is consistent with Archrock’s fourth quarter 2023 dividend and represents a year-over-year...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.